Device evaluation the zilver ptx 35 drug-eluting stent devices of unknown rpns and unknown lot numbers involved in this complaint were implanted in the patients and were not available for evaluation.With the information provided, a document-based investigation was conducted manufacturing records prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.Manufacturing records review could not be completed as the lot number is unknown.Review historical data historical data was not reviewed as the lot number is unknown.Instructions for use/label there is no evidence to suggest that the customer did not follow the instructions for use (ifu0118).It should be noted that arterial thrombosis is listed as a potential adverse event related to the device in the instructions for use.Image review an image was not returned for evaluation.Root cause review a root cause could not be concluded from the limited information available.Possible root causes may be attributed to the patients underlying conditions or pre existing conditions.Numerous attempts were made to gain more information in regards to this complaint but no further information was available.Should more information become available at a later stage, the file can be re-assessed and updated accordingly.As previously mentioned, arterial thrombosis is listed as a potential adverse event related to the device in the instructions for use.Confirmation of complaint complaint is confirmed based on customer and/or rep testimony summary according to the initial reporter, zilver ptx implanted, 12 cases of acute thrombosis post implant.Implant and date of occurrence is around 2015-2016.Confirmed quantity of 12 devices, confirmed used.From the initial reporter, we do not know the patient outcome after the 12 instances of acute thrombosis post implant.Should more information become available at a later stage, the file can be re-assessed and updated accordingly investigation findings conclude definitive root cause could not be determined due to the limited information available.Should additional information become available the complaint will be reopened and updated accordingly.Possible root causes may be attributed to the patients underlying conditions or pre existing conditions.As previously mentioned, arterial thrombosis is listed as a potential adverse event related to the device in the instructions for use complaints of this nature will continue to be monitored for potential emerging trends.
|